atazanavir


Also found in: Medical, Wikipedia.
Related to atazanavir: Abacavir, Truvada
Translations

atazanavir

n atazanavir m
References in periodicals archive ?
l- Tenofivir 300 mg + Lamivudine 300 mg tablets-17,628,240, II-Zidovudine 300 mg + Lamivudine150mg tablets-41,280,000, Efavirenz 600 mg tablets-13494,000, Atazanavir 300 mg + Ritonavir 100 mgtablets-11,639,790 tabs, Lopinavir200 mg + Ritonavir 50 mg tablets- 9,209,640
Another study, however, found only a minimal difference between EFV and another PI, atazanavir (ATV).
The pill is slightly more effective than Atripla as well as Truvada combined with atazanavir and ritonavir.
Potential genotypic-phenotypic correlations for drug-associated adverse events, or potential mechanisms for such events, have been elucidated for several antiretroviral agents, including nevirapine, atazanavir, efavirenz, tenofovir and abacavir.
Reyataz, or atazanavir sulfate capsules, are used in combination with other medications to control HIV infection.
8) They already have it in a trial to boost the integrase inhibitor elvitegravir in combination with tenofovir/emtricitabine (9) and in another trial comparing it with ritonavir to boost atazanavir.
This edition adds about 200 new and revised monographs, including interactions between anticoagulants and glucosamine, atazanavir and MAOIs, naladixic acid and melphalan, and tacrolimus and barbiturates.
The combination of ritonavir-boosted atazanavir plus two NRTIs has been shown to be effective in suppressing viral replication and is recommended as one of the initial regimens.
Both the ARTEMIS and the CASTLE studies suggest that in PI-naive patients, both atazanavir and darunavir can be boosted with 100 mg of ritonavir, which is an advantage.
Interim results from the study, which involves patients taking anti-HIV treatment for the first time, showed that a once-daily antiretroviral combination of atazanavir, FTC and enteric-coated ddI (ddI-EC) was associated with poorer control of HIV.
McCallister was director of Virology, Global Medical Affairs for Bristol Myers Squibb Company, where he was responsible for the global medical strategy of the anti-HIV protease inhibitor, atazanavir (REYATAZ), and coordinated the review and approval of other virology studies, both internal and external, at BMS.